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Abstract 
This pilot study tested the validity of a one-item visual assessment method originally 
developed to evaluate suffering in chronic illness that has been adapted for use with patients 
who had been exposed to traumatic events. The Pictorial Representation of Illness and Self 
Measure (PRISM) was administered five times during the course of a posttraumatic stress 
disorder (PTSD) treatment outcome study (N = 29). PRISM scores declined significantly 
under trauma-focused psychotherapy and differentiated between participants with and 
without PTSD diagnoses. Test-retest reliability over a six month period was high (r = .85). 
PRISM showed significant correlations with measures of PTSD, depression, and 
psychopathology symptom load (r = -.38 to r = -.81; convergent validity). At the same time, 
PRISM was not significantly related to trauma history (discriminant validity). Illustrations of 
symptom time courses indicated that PRISM was more closely related to trauma-specific 
psychopathology than to non trauma-specific psychopathology (discriminant validity) and 
sensitive to change. In summary, PRISM appears to be a valid tool for the assessment of 
trauma-related suffering and may be considered an important expansion of multi-method 
approaches in trauma research. 
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     Trauma-related assessment tools typically reflect individual diagnostic entities such as 
posttraumatic stress disorder (PTSD; American Psychiatric Association, 1994) or other 
constructs such as posttraumatic cognitions (Foa, Tolin, Ehlers, Clark, & Orsillo, 1999). To 
our knowledge, no single measure assesses the perceived impact (rather than mere 
occurrence) of the consequences of a given traumatic experience in a comprehensive way 
allowing for consideration of all individually relevant dimensions (e.g., psychopathology, 
physical health, work situation, social circumstances). We assume that the construct of 
trauma-related suffering is best suited to reflect the entirety of this subjective experience 
(impact). Trauma-related suffering results from a complex interaction between psychological, 
physical, and social sequelae of a traumatic event, including relevant aspects of the individual 
concerned (e.g., personality traits, value systems, social resources). 
     Pictorial Representation of Illness and Self Measure (PRISM) has been developed as a 
visualization tool to measure the burden of suffering and has successfully been validated in 
various conditions such as chronic illness (i.e., Buchi, et al., 2002) and pain (i.e., Streffer, 
Büchi, Mörgeli, Galli, & Ettlin, 2009). As part of a randomized controlled trial (RCT) of 
Brief Eclectic Psychotherapy (BEP) for PTSD (Schnyder, Müller, Maercker, & Wittmann, 
2011), we performed a pilot study on the validity of PRISM as a measure of trauma-related 
suffering. 
Method 
     The study protocol was approved by the Ethics Committee of the Canton of Zurich. 
Written informed consent was obtained from all participants. 
Participants 
     The main inclusion criterion was a total score of at least 50 points on the Clinician 
Administered PTSD Scale (CAPS; Blake, et al., 1998), resulting in a current diagnosis of full 
or subsyndromal (Blanchard, Hickling, Taylor, & Loos, 1995) PTSD in relation to traumatic 
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exposure at least six months prior to entering the RCT. Fluency in German and age between 
18 and 70 were additional inclusion criteria. Exclusion criteria were psychotic, bipolar, 
substance-related, or severe personality disorders; current severe depression; severe cognitive 
impairment or a history of organic mental disorder; ongoing traumatization; prominent 
current suicidal or homicidal ideation, unstable psychotropic medication, and asylum-seeking 
status. 
Measures 
     Pictorial Representation of Illness and Self Measure (PRISM; Buchi et al., 2002) consists 
of a white metal board measuring 210 × 297 mm (A4 format) with a fixed yellow disk (7 cm 
diameter) at the bottom right-hand corner, representing the patient’s “Self” (Fig. 1). Patients 
are given a red 5 cm diameter magnetic disk and instructed to imagine that the disk represents 
their illness (in this study: trauma). They are asked to place this red disk on the metal board 
after receiving the following instruction: “Where would you put the illness (trauma) disk to 
illustrate its place in your life right now?” The main quantitative measure derived from 
PRISM is the “Self-Illness-Separation”, or in this study “Self-Trauma-Separation” (STS), i.e. 
the distance between the centers of the “trauma” and the “self” disks ranging from 0 to 270 
mm with higher STS distances reflecting lesser suffering. PRISM’s convergent and 
discriminant validity have been demonstrated by the presence and absence of correlations 
between specific physical and psychological variables, different profiles of these correlations 
in different illnesses, and changes in PRISM scores accompanying changes in physical state 
(Buchi et al., 2002). Qualitative analyses of the individual meaning of the distance between 
Self and Illness detected three main aspects: 1. loss of control and personal autonomy, 2. loss 
of social or personal roles, and 3. increase in symptoms (Buchi et al., 2002). 
     PTSD symptoms during the last month were assessed with the CAPS (Blake et al., 1998; 
range = 0 - 136) and Part B of the Posttraumatic Diagnostic Scale (PDS; Foa, Cashman, 
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Jaycox, & Perry, 1997; range = 0 - 51)). Current axis I and II psychopathology was measured 
using the Structured Clinical Interview for DSM-IV (First, Gibbon, Spitzer, & Williams, 
1996; First, Spitzer, Gibbon, & Williams, 1996). Depression during the previous few days 
was assessed applying the Hospital Anxiety and Depression Scale (HADS; Zigmond & 
Snaith, 1983; range = 0 - 21). For the assessment of psychopathological symptom load during 
last seven days, we used the validated German nine-item short version SCL-K-9 (Klaghofer 
& Brähler, 2001) of the Symptom Checklist-90-R, the total score of which (global severity 
index, GSI, range = 0 - 36) proved to correlate almost perfectly (r = .93) with the GSI of the 
SCL-90-R in a representative sample of the German general population (Klaghofer & 
Brähler, 2001). Trauma history was assessed using Part A of the PDS and the Childhood 
Trauma Questionnaire (CTQ; Bernstein, et al., 2003). 
Procedure 
     Thirty patients fulfilled the inclusion criteria and were randomly assigned to either 16 
sessions of BEP (n = 16) or a minimal attention control condition (n = 14). As the control 
group was offered identical treatment after 16 weeks in the control condition, data from both 
groups were pooled together for the current analyses based on pre-treatment, post-treatment, 
and six month follow-up assessments. Additionally, patients completed PRISM, PDS, and 
SCL prior to therapy sessions seven and thirteen. One patient who refused treatment after the 
control condition was excluded from the present analyses, resulting in a total sample size of 
29. 
Statistical analyses 
     Statistical tests were performed using SPSS version 19. Effects of the factors time and 
PTSD diagnostic status on PRISM STS were tested by one-factorial general linear models 
(GLM) or t-tests. Due to the limited sample size, differences between the three diagnostic 
groups were quantified by effect sizes (Cohen’s d) rather than calculating post-hoc 
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comparisons. Correlations assessed PRISM’s test-retest reliability from post-therapy to 
follow-up assessment and its association with measures of psychopathology (convergent 
validity) and trauma history (discriminant validity). If PRSIM STS reflects trauma-related 
suffering – which we assume to result from the interaction of trauma sequelae with 
characteristics of the individual concerned – it should not be associated with the mere 
occurrence of traumatic events. To further examine PRISM’s discriminant validity and 
sensitivity to change, changes over time in PRISM STS and trauma-specific and non trauma-
specific markers were shown at the available assessment time points. The values of these four 
measures were transformed into T scores with a mean of 50 and a standard deviation of 10. 
Results 
     Descriptives (pre-treatment assessment): Thirteen participants (45%) were females; mean 
age of the sample was 43.0 (SD = 14.0) years. Eighteen participants (62%) were of Swiss 
nationality, eleven (38%) were on stable psychotropic medication. “Index” traumatic events 
included serious accidents (n = 13), violent sexual or non-sexual assaults (n = 8), and other 
traumatic events (n = 8). The median of time lapsed since the “index” trauma was 1.8 years 
(range = 0.5 – 50.5). Nineteen patients (66%) were diagnosed with full PTSD, the remaining 
ten (35%) with subsyndromal PTSD. Mean pre-treatment CAPS score was 71.6 (SD = 17.7). 
Nineteen patients (66%) received a comorbid axis I diagnosis, with anxiety (41%) and mood 
(38%) disorders being the most prominent. Seven of them received an additional comorbid 
axis II diagnosis. 
     PRISM STS time course: PRISM STS mean scores were 35.2 (SD = 43.0, N = 29) at pre-
treatment, 83.9 (SD = 82.8, n = 27) at post-treatment, and 95.4 (SD = 84.8, n = 24) at follow 
up assessment. A GLM detected a significant effect of time (F(1.69, 24) = 14.37, p < .001, 
partial eta2 = .39). Subsequent paired t-tests indicated a significant decline from pre- to post-
treatment assessment (t(26) = -3.78, p < .001, d = 0.7) which was maintained during the 
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follow-up interval (t(23) = -0.42, p = .679, d = 0.1). Test-retest reliability from post-therapy 
to follow-up assessment was r = .85 (p < .001, n = 24). 
     Association of PRISM STS and diagnostic status: A t-test indicated significant STS 
differences (t(27) = 2.27, p = .031, d = -0.8) between patients with full (M = 22.9, SD = 34.3, 
n = 19) and subsyndromal (M = 58.5, SD = 50.0, n = 10) PTSD at pre-treatment assessment. 
All participants had at least a sub-syndromal PTSD diagnosis at pre-treatment assessment. At 
post-treatment, a significant main effect for diagnostic status (F(2, 27) = 15.44, p < .001, 
partial eta2 = .56) with respect to PRISM STS was detected (full PTSD: M = 36.1, SD = 37.8, 
n = 14; subsyndromal PTSD: M = 71.0, SD = 56.4, n = 5; no PTSD diagnosis: M = 175.6, SD 
= 81.6, n = 8). Effect sizes indicated substantial differences for STS between subjects with no 
vs. subsyndromal PTSD (d = 1.5), subsyndromal vs. full PTSD (d = -0.7), and no vs. full 
PTSD (d = 2.2). Similarly, a significant main effect for diagnostic status (F(2, 24) = 7.75, p = 
.003, partial eta2 = .43) with respect to PRISM STS was detected at follow-up assessment 
(full PTSD: M = 37.2, SD = 30.1, n = 9; subsyndromal PTSD: M = 95.0, SD = 80.7, n = 8; no 
PTSD diagnosis: M = 170.7, SD = 83.9, n = 7). Effect sizes reflecting differences in STS 
between diagnostic groups were d = 0.9 for no vs. subsyndromal PTSD, d = 1.0 for 
subsyndromal vs. full PTSD, and d = 2.1 for no vs. full PTSD. 
     Convergent validity: Strong correlations between PRISM STS and measures of PTSD 
severity and depression were observed at all time points (Table 1). As for SCL GSI, 
correlations were in the moderate range at pre-treatment, and strong at later assessment time 
points. 
     Discriminant validity and sensitivity to change: Childhood traumatic experiences and 
number of trauma types (lifetime) were not significantly related to PRISM STS (Table 1). 
Figure 2 illustrates the time course of T scores of PRISM STS, PDS, SCL-9 GSI, as well as 
HADS-depression subscale over time. PRISM STS and PDS T scores appeared to be closely 
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associated from pre- to post-treatment, with only a minor difference at follow-up assessment. 
At the same time, their time course apparently differed from that of the HADS-depression 
and SCL-9 GSI, which appear to be closely associated with one another. 
Discussion 
     This study applied a validated instrument for the assessment of suffering in chronic 
illness, adapted for use in trauma research, in a sample of severely traumatized patients 
undergoing trauma-focused psychotherapy. As expected, trauma-related suffering 
significantly declined under psychotherapy for PTSD. Test-retest reliability during follow-up 
interval was high. PRISM discriminated well between subjects with full, subsyndromal, and 
no PTSD diagnosis and showed strong correlations with measures of trauma-specific and 
non-specific psychopathology (convergent validity). We assume that the somewhat less 
pronounced correlations at pre-treatment assessment can be explained by the restricted range 
of CAPS scores at baseline. The absence of a significant relationship between PRISM and 
trauma history and illustration of PRISM STS time course combined with measures of 
psychopathology indicate PRISM’s discriminant validity as a measure of trauma-related 
suffering as well as sensitivity to change. 
     This study has a number of limitations that need to be considered. First, the small sample 
size raises questions regarding the representativity of our results. Furthermore, a replication 
study should include patients reporting type II traumatic events (Terr, 1991), collect 
qualitative data on how trauma survivors interpret the PRISM instructions, and compare 
PRISM STS to putatively related constructs such as centrality (Berntsen & Rubin, 2006). 
Notwithstanding these limitations, we believe that PRISM could make a valuable 
contribution to the field of traumatic stress. Given that the alleviation of suffering is one of 
the main goals of medicine (Cassell, 1982), the significance of its scope and value in 
assessing trauma survivors, in addition to existing trauma-related constructs, seems evident. 
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Table 1: Correlations between PRISM STS and Measures of Psychopathology and 
Traumatization 
 
Variable  Pre-treatment Post-treatment Follow-up 
CAPS total score r -.53** -.74*** -.76*** 
 n 29 27 24 
PDS total score r -.49* -.77*** -.81*** 
 n 25 25 22 
HADS-depression score r -.55** -.69*** -.81*** 
 n 25 25 22 
SCL-9 GSI r -.38 -.68*** -.60** 
 n 25 25 23 
CTQ total score r -.18 - - 
 n 27 - - 
Number of trauma types r .20 - - 
 n 29 - - 
* p < .05, ** p < .01, *** p < .001 
 
Abbreviations: PRISM, Pictorial Representation of Illness and Self Measure; STS, Self-
Trauma-Separation; CAPS Clinician Administered PTSD Scale; HADS, Hospital Anxiety and 
Depression Scale; SCL-9 GSI, Global Severity Index of Symptom Check-List Short Version 
9; CTQ, Childhood Trauma Questionnaire 
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